Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging

Abstract

Accurately measuring resilience to preclinical Alzheimer’s disease (AD) pathology is essential to understanding an important source of variability in cognitive aging. In a cohort of cognitively normal older adults (n = 123, age 76.75 ± 6.15 yr), we built a multifactorial measure of resilience which moderated the effect of AD pathology on longitudinal cognitive change. Linear residuals-based measures of resilience, along with other proxy measures (education and vocabulary), were entered into a hierarchical partial least-squares path model defining a putative consolidated resilience latent factor (model goodness of fit = 0.77). In a set of validation analyses using linear mixed models predicting longitudinal cognitive change, there was a significant three-way interaction among consolidated resilience, tau and time on episodic memory change (P = 0.001) such that higher resilience blunted the effect of tau pathology on episodic memory decline. Interactions between consolidated resilience and amyloid pathology on non-memory cognition decline suggested that resilience moderates pathology-specific effects on different cognitive domains.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CFA of two cognitive domains.
Fig. 2: PLS path model defining consolidated resilience.
Fig. 3: Consolidated resilience and ERC FTP interact to predict change in episodic memory.
Fig. 4: Interactive associations of consolidated resilience and global PiB DVR on cognitive domain scores.

Similar content being viewed by others

Data availability

Data used in this study (PET images, magnetic resonance images and cognitive data) will be shared by request from any qualified investigator subject to the negotiation of a data use agreement. Controlled access to human subjects data is required by the reviewing IRB and only deidentified data may be shared. Requests for data will be answered promptly and should be directed to W.J.J. (jagust@berkeley.edu).

References

  1. Price, J. L. & Morris, J. C. Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer’s disease. Ann. Neurol. 45, 358–368 (1999).

    Article  CAS  PubMed  Google Scholar 

  2. Jack, C. R. et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 9, 119 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Katzman, R. et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138–144 (1988).

    Article  CAS  PubMed  Google Scholar 

  4. Stern, Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 8, 448–460 (2002).

    Article  PubMed  Google Scholar 

  5. Arenaza-Urquijo, E. M. & Vemuri, P. Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology 90, 695–703 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Arenaza-Urquijo, E. M. & Vemuri, P. Improving the resistance and resilience framework for aging and dementia studies. Alzheimer’s Res. Ther. 12, 1–4 (2020).

    Google Scholar 

  7. Stern, Y. et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer’s Dement. 16, 1305–1311 (2020).

    Article  Google Scholar 

  8. Nelson, M. E., Jester, D. J., Petkus, A. J. & Andel, R. Cognitive reserve, Alzheimer’s neuropathology, and risk of dementia: A systematic review and meta-analysis. Neuropsychol. Rev. 31, 233–250 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bocancea, D. I. et al. Measuring resilience and resistance in aging and Alzheimer disease using residual methods: A systematic review and meta-analysis. Neurology 97, 474–488 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stern, Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 11, 1006–1012 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kremen, W. S. et al. Influence of young adult cognitive ability and additional education on later-life cognition. Proc. Natl Acad. Sci. U. S. A. 116, 2021–2026 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Reed, B. R. et al. Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain 133, 2196–2209 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zahodne, L. B. et al. Is residual memory variance a valid method for quantifying cognitive reserve? A longitudinal application. Neuropsychologia 77, 260–266 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hohman, T. J. et al. Asymptomatic Alzheimer disease: Defining resilience. Neurology 87, 2443–2450 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dumitrescu, L. et al. Genetic variants and functional pathways associated with resilience to Alzheimer’s disease. Brain 143, 2561–2575 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mungas, D. et al. Comparison of education and episodic memory as modifiers of brain atrophy effects on cognitive decline: Implications for measuring cognitive reserve. J. Int. Neuropsychol. Soc. 27, 401–411 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Salthouse, T. A. When does age-related cognitive decline begin? Neurobiol. Aging 30, 507–514 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nelson, P. T. et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J. Neuropathol. Exp. Neurol. 71, 362–381 (2012).

    Article  PubMed  Google Scholar 

  19. Maass, A. et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J. Neurosci. 38, 530–543 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rentz, D. M. et al. Cognitive resilience in clinical and preclinical Alzheimer’s disease: The association of amyloid and Tau burden on cognitive performance. Brain Imaging Behav. 11, 383–390 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ossenkoppele, R. et al. Assessment of demographic, genetic, and imaging variables associated with brain resilience and cognitive resilience to pathological Tau in patients with Alzheimer disease. JAMA Neurol. 77, 632–642 (2020).

    Article  PubMed  Google Scholar 

  22. Franzmeier, N. et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease. Brain 141, 1186–1200 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Franzmeier, N., Duering, M., Weiner, M., Dichgans, M. & Ewers, M. Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease. Neurology 88, 1054–1061 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Neitzel, J., Franzmeier, N., Rubinski, A. & Ewers, M. Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory. Neurology 93, E347–E357 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Roe, C. M. et al. Alzheimer disease and cognitive reserve: Variation of education effect with carbon 11-labeled pittsburgh compound B uptake. Arch. Neurol. 65, 1467–1471 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bennett, D. A. et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60, 1909–1915 (2003).

    Article  CAS  PubMed  Google Scholar 

  27. Landau, S. M. et al. Association of lifetime cognitive engagement and low β-amyloid deposition. Arch. Neurol. 69, 623–629 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  28. Farrell, M. E. et al. Association of emerging β-amyloid and Tau pathology with early cognitive changes in clinically normal older adults. Neurology 98, e1512–e1524 (2022).

    Article  CAS  PubMed  Google Scholar 

  29. Baker, J. E. et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer’s Dement.: Diagnosis, Assess. Dis. Monit. 6, 108–121 (2017).

    Google Scholar 

  30. Jack, C. R. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement 14, 535–562 (2018).

    Article  Google Scholar 

  31. Schaeverbeke, J. M. et al. Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Alzheimer’s Res. Ther. 2021 131 13, 1–16 (2021).

    Google Scholar 

  32. Harrison, T. M. et al. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.Neurobiol. Aging 67, 162–170 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Habeck, C. et al. Cognitive reserve and brain maintenance: Orthogonal concepts in theory and practice. Cereb. Cortex 27, 3962–3969 (2016).

    PubMed Central  Google Scholar 

  34. Elman, J. A. et al. Issues and recommendations for the residual approach to quantifying cognitive resilience and reserve. Alzheimers Res. Ther. 14, 102 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  35. Dodge, H. H., Wang, C. N., Chang, C. C. H. & Ganguli, M. Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology 77, 722–730 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  36. Logan, J. et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16, 834–840 (1996).

    Article  CAS  PubMed  Google Scholar 

  37. Price, J. C. et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow. Metab. 25, 1528–1547 (2005).

    Article  CAS  PubMed  Google Scholar 

  38. Mormino, E. C. et al. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cereb. Cortex 21, 2399–2407 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Villeneuve, S. et al. Existing Pittsburgh compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138, 2020–2033 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Baker, S. L. et al. Reference tissue-based kinetic evaluation of 18F-AV-1451 for Tau imaging. J. Nucl. Med. 58, 332–338 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Baker, S. L., Maass, A. & Jagust, W. J. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Br. 15, 648–657 (2017).

    Article  Google Scholar 

  42. Rousset, O. G., Ma, Y. & Evans, A. C. Correction for partial volume effects in PET: Principle and validation. J. Nucl. Med. 39, 904–911 (1998).

    CAS  PubMed  Google Scholar 

  43. Jack, C. R. et al. Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimer’s Dement. 13, 205–216 (2017).

    Article  Google Scholar 

  44. Hu, L. & Bentler, P. M. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct. Equ. Model. A Multidiscip. J. 6, 1–55 (1999).

    Article  Google Scholar 

  45. Mungas, D., Widaman, K. F., Reed, B. R., & Tomaszewski Farias, S. Measurement invariance of neuropsychological tests in diverse older persons. Neuropsychology 25, 260–269 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  46. Allison Bender, H. et al. Construct validity of the Neuropsychological Screening Battery for Hispanics (NeSBHIS) in a neurological sample. J. Int. Neuropsychol. Soc. 15, 217–224 (2009).

    Article  PubMed  Google Scholar 

  47. DiStefano, C., Zhu, M. & Mîndrilã, D. Understanding and using factor scores: Considerations for the applied researcher. Pract. Assess., Res. Eval. 14, 20 (2009).

    Google Scholar 

  48. Sanchez, G. PLS Path Modeling with R (Trowchez Editions, 2013).

Download references

Acknowledgements

This research was supported by the National Institutes of Health grants R03-AG067033 (to T.M.H) and R01-AG034570 and R01-AG062542 (to W.J.J.). Support was also provided by the Tau Consortium (to W.J.J). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Avid Radiopharmaceuticals enabled the use of the [18 F] FTP tracer but did not provide direct funding and were not involved in data analysis or interpretation.

Author information

Authors and Affiliations

Authors

Contributions

T.M.H., D.M. and W.J.J. contributed to the conception and design of the study. L.D., K.Z., S.L.B. and T.M.H. contributed to the acquisition, curation and analysis of the data. L.D. and T.M.H. wrote the original manuscript draft. All authors contributed to drafting the final manuscript and figures.

Corresponding author

Correspondence to Theresa M. Harrison.

Ethics declarations

Competing interests

The authors have no competing interests.

Peer review

Peer review information

Nature Aging thanks Eric Westman and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Tables 1–4 and Figures 1–3.

Reporting Summary

Source data

Source Data Fig. 3

Numerical data used to run linear mixed effects models and create plots.

Source Data Fig. 4

Numerical data used to run linear mixed effects models and create plots.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dobyns, L., Zhuang, K., Baker, S.L. et al. An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging. Nat Aging 3, 229–237 (2023). https://doi.org/10.1038/s43587-022-00353-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43587-022-00353-2

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing